Endovia Health Sciences, Inc. EDVA
Beverages (Production/Distribution) · IPO 2021 · data as of November 13, 2026
Endovia Health Sciences, Inc. (EDVA) is a consumer staples company listed in the US with a market value of about $2M. In the twelve months to June 30, 2026 it had revenue of $32090 and net income of -$17M, a net margin of -53856.5%.
Its overall Stock Analiz score is 0.2 out of 5 (weak). The strongest part is track record (1/5); the weakest is value (0/5).
Key numbers: 5-year revenue growth of -52% a year, a 5-year average ROIC of -228%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 100% below the current price.
About Endovia Health Sciences
Endovia Health Sciences is listed in the US and classified in beverages (production/distribution), IPO year 2021. Revenue went from $605905 in 2014 to $73066 in 2025, a decline of about 17.5% a year. It was profitable in 1 of the last 10 years in our data. Its share count rose by 133% over three years (dilution for shareholders).
Score: 0.2 / 5
Checks passed
- ROE above 15%
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $32090 | $73066 | $801273 | $19M | $18M | $11M | $3M | $20387 | $1M | $895346 | $1M |
| Net income | -$17M | -$25M | -$24M | -$21M | -$22M | -$29M | -$29M | -$5M | $68206 | -$147534 | -$48846 |
| Free cash flow | — | — | -$7M | -$10M | -$14M | -$15M | -$21M | -$3M | -$13241 | -$75872 | -$26311 |
| EPS (diluted) | $-6.15 | $-11.97 | $-17.68 | $-19.79 | $-23.20 | $-40.80 | $-42.40 | $-1.60 | $0.40 | $-0.40 | $0.00 |
| Net margin | -53856.5% | -34537.0% | -2964.8% | -111.4% | -119.9% | -256.7% | -963.6% | -25191.2% | 5.2% | -16.5% | -4.8% |
| ROIC | — | — | — | -382.2% | -123.5% | -178.6% | — | — | — | — | -52.0% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
Is Endovia Health Sciences stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 100% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Endovia Health Sciences pay a dividend?
Not currently.
Is Endovia Health Sciences a good stock to buy?
We do not give buy or sell advice. Endovia Health Sciences scores 0.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.